The use of angiotensin II receptor blocker is associated with greater recovery of cardiac function than angiotensin‐converting enzyme inhibitor in dilated cardiomyopathy

Abstract Aims Angiotensin‐converting enzyme inhibitors (ACEis) or angiotensin II receptor blockers (ARBs) have been shown to be associated with recovery of cardiac function in patients with dilated cardiomyopathy (DCM). The aim of this study was to assess comparative effectiveness of ACEis vs. ARBs...

Descripció completa

Dades bibliogràfiques

Autors principals:	Nobuyuki Enzan, Shouji Matsushima, Tomomi Ide, Takeshi Tohyama, Kouta Funakoshi, Taiki Higo, Hiroyuki Tsutsui
Format:	Artigo
Idioma:	Inglês
Publicat:	Oxford University Press 2022-04-01
Col·lecció:	ESC Heart Failure
Matèries:	Dilated cardiomyopathy Heart failure with reduced ejection fraction Angiotensin‐converting enzyme inhibitor Angiotensin II receptor blocker
Accés en línia:	https://doi.org/10.1002/ehf2.13790
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!